Deep Brain Stimulation for Parkinson's Disease-the Developing World's Perspective

被引:1
|
作者
Patel, Khushboo [1 ]
Puthanveedu, Divya Kalikavil [1 ]
Vijayaraghavan, Asish [1 ]
Kesavapisharady, Krishnakumar [1 ]
Sarma, Gangadhara [1 ]
Sarma, Sankara P. [2 ]
Krishnan, Syam [1 ,3 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMST, Comprehens Care Ctr Movement Disorders, Thiruvananthapuram, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram, India
[3] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMST, Comprehens Care Ctr Movement Disorders, Neurol, Thiruvananthapuram, Kerala, India
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2023年 / 10卷 / 12期
关键词
Parkinson's disease; deep brain stimulation; developing country; quality of life; patient selection; ADVANCED PARKINSONS-DISEASE; SUBTHALAMIC STIMULATION; MEDICAL THERAPY; PROGRESSION; KUPPUSWAMY; OUTCOMES; SURGERY; PLUS;
D O I
10.1002/mdc3.13901
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundDeep brain stimulation (DBS) is the most widely used device-assisted therapy in patients with moderately advanced stages of Parkinson's disease (PD) experiencing motor complications. Only a minority of eligible patients get the opportunity to undergo DBS in the developing world.ObjectivesTo examine the proportion and characteristics of patients with motor complications of PD who are willing for DBS and who undergo surgery.MethodsPatients with motor complications of PD eligible for DBS over a five-year study period (2016-2020) were included. The demographic, clinical and socio-economic characteristics and information on their status in 2021 were collected and analyzed.ResultsAmong 1017 patients, 223 had motor symptoms qualifying for DBS and follow-up information available. Only 78 (35%) opted for surgery. The willing patients had higher socioeconomic status, were older and had longer duration of PD and motor complications, more freezing of gait, cognitive symptoms, and neuropsychiatric disturbances. 37 of them were found unfit during pre-operative work-up; only 41 (18%) with motor complications were finally taken up for DBS. Age, duration or severity of motor symptoms did not differ between patients who were finally selected for surgery and those who were not.ConclusionsLess than one-fifth of our patients with motor complications of PD finally underwent DBS. The patients appeared to wait till the late stages of PD, before making a decision on availing surgical treatment. The delay resulted in nearly half of them being found unfit in pre-operative work-up. Our findings may enable clinicians to counsel eligible patients more efficiently.
引用
收藏
页码:1750 / 1758
页数:9
相关论文
共 50 条
  • [1] Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
    Prajjwal, Priyadarshi
    Kolanu, Nikhil Deep
    Reddy, Yeruva Bheemeswara
    Ahmed, Aneeqa
    Marsool, Mohammed Dheyaa Marsool
    Santoshi, Krupanagram
    Pattani, Himani Harshad
    John, Jobby
    Chandrasekar, Kiran Kishor
    Hussin, Omniat Amir
    HEALTH SCIENCE REPORTS, 2024, 7 (04)
  • [2] Parkinson's Disease Psychosis and the Marketing of Pimavanserin
    Daeschler, Daisy
    Fugh-Berman, Adriane
    INTERNATIONAL JOURNAL OF SOCIAL DETERMINANTS OF HEALTH AND HEALTH SERVICES, 2024, : 272 - 284
  • [3] The role of membrane trafficking and retromer complex in Parkinson's and Alzheimer's disease
    Abdul-Rahman, Toufik
    Ghosh, Shankhaneel
    Kalmanovich, Jacob B.
    Awuah, Andrew Wireko
    Zivcevska, Marija
    Khalifa, Samar
    Bassey, Esther Edet
    Ali, Namarig Alnil
    Ferreira, Matheus Mendes dos Santos
    Umar, Tungki Pratama
    Garg, Neil
    Nweze, Victor Nnanna
    Inturu, Venkata Sai Sulekhya
    Abdelwahab, Maya Magdy
    Kurian, Sneha
    Alexiou, Athanasios
    Alfaleh, Mohammed
    Alqurashi, Thamer M. A.
    Ashraf, Ghulam Md
    JOURNAL OF NEUROSCIENCE RESEARCH, 2024, 102 (01)
  • [4] A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease
    Ghosh, Nabanita
    Sinha, Krishnendu
    Sil, Parames C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (05) : 602 - 613
  • [5] Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases
    Netzahualcoyotzi, Citlalli
    Santillan-Cigales, Juan Jair
    Adalid-Peralta, Laura Virginia
    Velasco, Ivan
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (09) : 2316 - 2334
  • [6] Causal relationships between Sjögren's syndrome and Parkinson's disease: A Mendelian randomization study
    Wang, Jing
    Li, Yixuan
    Zhang, Ju
    Jiang, Huan
    Qi, Jiaping
    Gu, Qinchen
    Sun, Qiong
    Chen, Lin
    Jiang, Zhaoyu
    Liu, Aihui
    Ying, Zhenhua
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (03)
  • [7] Unveiling Assessment Gaps in Parkinson's Disease Psychosis: A Scoping Review
    Mangone, Graziella
    Tosin, Michelle H. S.
    Goetz, Christopher G.
    Stebbins, Glenn T.
    Mestre, Tiago A.
    MOVEMENT DISORDERS, 2024, 39 (03) : 560 - 570
  • [8] Parkinson's disease and vitamins: a focus on vitamin B12
    Rekik, Arwa
    Santoro, Carlo
    Poplawska-Domaszewicz, Karolina
    Qamar, Mubasher Ahmad
    Batzu, Lucia
    Landolfo, Salvatore
    Rota, Silvia
    Falup-Pecurariu, Cristian
    Murasan, Iulia
    Chaudhuri, Kallol Ray
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (12) : 1495 - 1509
  • [9] Istradefylline/L-DOPA Parkinson's disease therapy and energy coupling
    Kanzato, Naomi
    Nakachi, Koh
    Mochizuki, Satsuki
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2024, 12 (05): : 296 - 305
  • [10] Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases
    Rymbai, Emdormi
    Sugumar, Deepa
    Chakkittukandiyil, Amritha
    Kothandan, Ram
    Selvaraj, Divakar
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (03)